Q
QuantAbundanciaAbundância, quantificada.

Notícias

Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.

27,451 signal articles · 236 in last 24h · 132,834 total before filter · latest 54m ago
236last 24h
1169last 7d
204● bullish (7d)
124● bearish (7d)
208publishers
AllMacro282Earnings427M&A72Regulatory22Product10Analyst20
✕ clear all filtersSentiment:bullishneutralbearishshow all (incl. clickbait)
What Does Apple (AAPL) Risk From Its Trade Secrets Lawsuit?
Simply Wall St.1d agobearish
What Does Apple (AAPL) Risk From Its Trade Secrets Lawsuit?

Apple (NasdaqGS:AAPL) has filed a lawsuit against OpenAI and a former engineer over alleged theft of confidential circuit schematics and related trade secrets. The complaint accuses the former Apple employee of misappropriating proprietary hardware designs and integrating them into OpenAI projects. Apple is seeking damages, a preliminary injunction, and court orders to destroy any materials that allegedly contain its protected technology. The case adds fresh scrutiny to how major AI players...

Elon Musk Recalls SpaceX Nearly Failing After 3 Rocket Launches: ‘If the 4th Launch Had Failed, SpaceX Would Not Exist’
Benzinga1d agobearish
Elon Musk Recalls SpaceX Nearly Failing After 3 Rocket Launches: ‘If the 4th Launch Had Failed, SpaceX Would Not Exist’

While Space Exploration Technologies Corp. (NASDAQ:SPCX) is one of the biggest enterprises in the world today, this was not always the case, as CEO Elon Musk shared how repeated initial launch failures cast uncertainty over the future of the commercial spaceflight company. Peter Diamandis Recalls SpaceX’s Failures In a post on X on Sunday, X Prize Foundation‘s Executive Chairman Peter Diamandis shared how everyone knows the “trillion-dollar version of SpaceX,” but nobody remembered that “Elon’s

Amazon stock falls as FTC prepares ad-pricing lawsuit
InvestorsHub2d agobearish
Amazon stock falls as FTC prepares ad-pricing lawsuit

Key takeawaysThe FTC and more than 20 state attorneys general reportedly plan to sue Amazon over its advertising-auction practices. Regulators are expected to allege that undisclosed price floors increased advertisers’ costs and generated tens of billions of dollars for Amazon.

Protagonist Wins FDA Approval for MIMRYLO in Rare Blood Cancer Treatment
MarketBeat2d agobullish
Protagonist Wins FDA Approval for MIMRYLO in Rare Blood Cancer Treatment

Protagonist Therapeutics (NASDAQ:PTGX) said the U.S. Food and Drug Administration has approved rusfertide, to be marketed as MIMRYLO, for the treatment of erythrocytosis in adults with polycythemia vera, or PV. The approval marks the company’s second FDA-approved medicine this year, following the M

KKR Hit With $250 Million Penalty Over Antitrust Violations
Benzinga Private Markets6d agoneutral
KKR Hit With $250 Million Penalty Over Antitrust Violations

KKR & Co. (NYSE:KKR) is set to pay a $250 million civil penalty after the private equity firm allegedly violated the Hart-Cottrell-Rodino Act by withholding and altering documents and failing to make required filings. The HSR Act requires M&A parties...

China launches year-long auto quality drive, mandates defect recalls
Reuters6d agobearish
China launches year-long auto quality drive, mandates defect recalls

BEIJING, Aug 27 () - Chinese regulators on Thursday ordered automakers to file proactive recall plans for any defects uncovered in self-audits, ‌as part of a year-long campaign to improve vehicle quality ‌and safety in the world's largest auto market. Tesla and eight Chinese electric vehicle makers ​on August 21 announced fixes affecting a combined 4.

FDA Approves Abbott's First Wearable Device for Dual Ketone and Glucose Tracking
Benzinga7d agoneutral
FDA Approves Abbott's First Wearable Device for Dual Ketone and Glucose Tracking

The U.S. Food and Drug Administration (FDA) on Tuesday approved Abbott Laboratories’ (NYSE:ABT) Libre Duo 10 Day Continuous Dual Glucose Ketone Monitoring System for diabetes patients aged two and older. The regulatory nod makes the device the first wearable in the U.S. to monitor ketone levels continuously. It also represents the first global system to track blood sugar and ketones simultaneously within a single unit. Clinical Data And De Novo Pathway The agency granted marketing authorization